MeSH Review:
Coxsackievirus Infections
- Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy. Jenson, H.B., Gauntt, C.J., Easley, K.A., Pitt, J., Lipshultz, S.E., McIntosh, K., Shearer, W.T. J. Infect. Dis. (2002)
- Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3. So, E.Y., Kang, M.H., Kim, B.S. Glia (2006)
- Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease. Ilbäck, N.G., Wesslén, L., Pauksen, K., Stålhandske, T., Friman, G., Fohlman, J. Scandinavian journal of infectious diseases. Supplementum. (1993)
- Coxsackieviruses and pancreatitis. Ramsingh, A.I. Front. Biosci. (1997)
- Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Badorff, C., Lee, G.H., Lamphear, B.J., Martone, M.E., Campbell, K.P., Rhoads, R.E., Knowlton, K.U. Nat. Med. (1999)
- Susceptibility of skeletal muscle to Coxsackie A2 virus infection: effects of botulinum toxin and denervation. Andrew, C.G., Drachman, D.B., Pestronk, A., Narayan, O. Science (1984)
- Peroxynitrite inhibition of Coxsackievirus infection by prevention of viral RNA entry. Padalko, E., Ohnishi, T., Matsushita, K., Sun, H., Fox-Talbot, K., Bao, C., Baldwin, W.M., Lowenstein, C.J. Proc. Natl. Acad. Sci. U.S.A. (2004)
- RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. Flodström-Tullberg, M., Hultcrantz, M., Stotland, A., Maday, A., Tsai, D., Fine, C., Williams, B., Silverman, R., Sarvetnick, N. J. Immunol. (2005)
- Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. Zaragoza, C., Ocampo, C.J., Saura, M., Bao, C., Leppo, M., Lafond-Walker, A., Thiemann, D.R., Hruban, R., Lowenstein, C.J. J. Immunol. (1999)
- Current status of anti-picornavirus therapies. Barnard, D.L. Curr. Pharm. Des. (2006)
- Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff? Kerekatte, V., Keiper, B.D., Badorff, C., Cai, A., Knowlton, K.U., Rhoads, R.E. J. Virol. (1999)
- Coxsackie virus B3 perimyocarditis in BALB/c mice: experimental model of chronic perimyocarditis in the right ventricle. Matsumori, A., Kawai, C. J. Pathol. (1980)
- Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice. Yanagawa, B., Spiller, O.B., Proctor, D.G., Choy, J., Luo, H., Zhang, H.M., Suarez, A., Yang, D., McManus, B.M. J. Infect. Dis. (2004)
- dsRNA formed as an intermediate during Coxsackievirus infection does not induce NO production in a beta-cell line with or without addition of IFN-gamma. Berg, A.K., Elshebani, A., Andersson, A., Frisk, G. Biochem. Biophys. Res. Commun. (2005)